[
  {
    "info": {
      "NCT": "NCT04383210",
      "Protocol_No": "Not available",
      "jit": "Tempus",
      "trial_name": "Elevation Oncology"
    },
    "disease": {
      "summary": "Recurrent locally-advanced or metastatic solid tumors",
      "details": [
        {
          "code": "Solid Tumors",
          "selection": "include"
        },
        {
          "code": "Pancreas (PANCREAS)",
          "selection": "include"
        },
        {
          "code": "Lung (LUNG)",
          "selection": "include"
        },
        {
          "code": "Head and Neck (HEAD_NECK)",
          "selection": "include"
        },
        {
          "code": "Breast (BREAST)",
          "selection": "include"
        },
        {
          "code": "Kidney (KIDNEY)",
          "selection": "include"
        },
        {
          "code": "Bowel (BOWEL)",
          "selection": "include"
        },
        {
          "code": "Bladder/Urinary Tract (BLADDER)",
          "selection": "include"
        },
        {
          "code": "Ovary/Fallopian Tube (OVARY)",
          "selection": "include"
        },
        {
          "code": "Sarcoma, NOS (SARCNOS)",
          "selection": "include"
        },
        {
          "code": "Gallbladder Cancer (GBC)",
          "selection": "include"
        },
        {
          "code": "Intraductal Papillary Neoplasm of the Bile Duct (IPN)",
          "selection": "include"
        },
        {
          "code": "Esophagus/Stomach (STOMACH)",
          "selection": "include"
        },
        {
          "code": "Endometrial Carcinoma (UCEC)",
          "selection": "include"
        },
        {
          "code": "Liver (LIVER)",
          "selection": "include"
        },
        {
          "code": "Prostate (PROSTATE)",
          "selection": "include"
        },
        {
          "code": "Solid Tumors",
          "selection": "include"
        }
      ]
    },
    "query": {
      "nct": "NCT04383210",
      "title": "Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors",
      "current_status": "Recruiting",
      "status_verif_date": "February 2022",
      "last_update_date": "September 12, 2022",
      "trial_hold_status": "open",
      "sponsor": "Elevation Oncology",
      "brief_summary": "This study is an open-label, international, multi-center, Phase 2 study in adult patients with recurrent, locally-advanced or metastatic solid tumors, which harbor the NRG1 gene fusion.",
      "conditions": "Locally Advanced Solid Tumor | Metastatic Solid Tumor | Pancreatic Cancer | Lung Cancer | Head and Neck Cancer | Breast Cancer | Kidney Cancer | Colorectal Cancer | Bladder Cancer | Ovarian Cancer | Sarcoma | Gallbladder Cancer | Bile Duct Cancer | Esophageal Cancer | Uterine Cancer | Cholangiocarcinoma | Prostate Cancer",
      "type": "Interventional",
      "phase": "Phase 2",
      "arm": [
        {
          "ArmID": "1",
          "cohortlabel": "Cohort 1",
          "drug": "Seribantumab",
          "arm_type": "Experimental",
          "line_of_therapy": "Not available",
          "arm_hold_status": "open",
          "biomarker": [
            {
              "cohort": "Cohort 1",
              "Gene": "NRG1",
              "Gene2": "Not available",
              "Type": "Fusion",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Not available",
              "summary": "NRG1 Fusion  "
            }
          ]
        },
        {
          "ArmID": "2",
          "cohortlabel": "Cohort 2",
          "drug": "Seribantumab",
          "arm_type": "Experimental",
          "line_of_therapy": "Not available",
          "arm_hold_status": "open",
          "biomarker": [
            {
              "cohort": "Cohort 2",
              "Gene": "NRG1",
              "Gene2": "Not available",
              "Type": "Fusion",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Not available",
              "summary": "NRG1 Fusion "
            }
          ]
        },
        {
          "ArmID": "3",
          "cohortlabel": "Cohort 3",
          "drug": "Seribantumab",
          "arm_type": "Experimental",
          "line_of_therapy": "Not available",
          "arm_hold_status": "open",
          "biomarker": [
            {
              "cohort": "Cohort 3",
              "Gene": "NRG1",
              "Gene2": "Not available",
              "Type": "Fusion",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Not available",
              "summary": "NRG1 Fusion"
            }
          ]
        }
      ],
      "docs": "Q:/MCK/MOA/Precision Oncology/JIT Trials/CarisPharmatechStudyList_2022-07-12.pdf",
      "min_age": "18 Years",
      "gender": "All",
      "link": "<a href=\"https://clinicaltrials.gov/ct2/show/NCT04383210\" target=\"_blank\">NCT04383210<\/a>"
    }
  }
]
